Pfizer And BioNtech Begin Clinical Trial For Omicron-Specific COVID-19 Vaccine
Published
Pfizer and BioNTech have started a clinical trial for their Omicron-specific COVID-19 vaccine.
Full ArticlePublished
Pfizer and BioNTech have started a clinical trial for their Omicron-specific COVID-19 vaccine.
Full ArticleThey are also testing a fourth dose of the current vaccine against a fourth dose of the Omicron-based vaccine in people who..